News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Compumedics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
Check Up: M&A activity in healthcare heats up as Aussie biotech Kinoxis attracts $181m from big pharma
Health & Biotech
Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?
News
Market Highlights: US inflation and 5 ASX small caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Immuron up 29pc on $6.2m travellers’ diarrhoea clinical study for US military
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
Health & Biotech
COVID-19 isn’t stopping ASX health stocks’ ambitions to make it in Europe and the US
Health & Biotech
Here’s why passing an FDA exam is so important for small caps like Compumedics
Health & Biotech
Health: Compumedics wins FDA approval for its brain scanners, leaps +20pc
News
10 at 10: These ASX stocks are rocking the stage this morning
Health & Biotech
Asia is where health investors are making money this year
News
Corporate: Compumedics shareholders did not like its revenue update this morning
Health & Biotech
Health: Get a load of this new brain scanner that Compumedics has installed
Health & Biotech
Health: Impression Healthcare to sell medicinal cannabis, conduct trials
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
Health & Biotech